Provided by Tiger Fintech (Singapore) Pte. Ltd.

Warren Buffett holdings

2,471.46
-62.0410-2.45%
Number of Gainers:16
Number of Losers:25
Number of Flat:2
PE:- -
High:2,526.04
Open:2,526.04
Low:2,445.85
Close:2,533.50
Loading ...

Johnson & Johnson Gets Health Canada Approval for Lung Cancer Drug Combination

MT Newswires Live
·
Yesterday

5 Low P/B Stocks to Add to Your Portfolio in March

Zacks
·
Yesterday

Johnson & Johnson's Investigational Colitis Treatment Meets Primary Endpoint in Phase 2b Trial

MT Newswires Live
·
Yesterday

Health Canada Authorizes Lazcluze® (Lazertinib) in Combination With Rybrevant® (Amivantamab) as a First-Line Chemotherapy-Free Treatment for Patients With Egfr-Mutated Advanced Lung Cancer

THOMSON REUTERS
·
Yesterday

Amazon's Competitors Reportedly Still Being Determined by FTC

MT Newswires Live
·
Yesterday

Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-small Cell Lung Cancer and Melanoma Indications

Business Wire
·
Yesterday

S&P 500 Suffers Worst Week Since September on Tariff Uncertainty

GuruFocus
·
Yesterday

Analysts Say 6 Rising Stocks Are Your Best Bets Amid Trump

Blockhead
·
Yesterday

Icotrokinra Meets Primary Endpoint of Clinical Response in Ulcerative Colitis Study and Shows Potential to Transform the Treatment Paradigm for Patients

THOMSON REUTERS
·
Yesterday

J&J: Icotrokinra Was Well Tolerated

THOMSON REUTERS
·
Yesterday

Icotrokinra meets primary endpoint of clinical response in ulcerative colitis study and shows potential to transform the treatment paradigm for patients

PR Newswire
·
Yesterday

Swing Big, Save Bigger: Topgolf and Verizon Team Up on Modern Golf Fun

PR Newswire
·
Yesterday

RiverPark Large Growth Fund’s Top Contributor: Amazon.com (AMZN)

Insider Monkey
·
Yesterday

DoorDash, Williams-Sonoma, and TKO Stock to Join the S&P 500 -- Barrons.com

Dow Jones
·
Yesterday

Egg prices have become a symbol of our economic fragility

Dow Jones
·
Yesterday

BRIEF-ElevateBio Collaborates With AWS To Broaden Potential Of Crispr Gene Editing Therapies With Generative AI

Reuters
·
Yesterday